The estimated Net Worth of Lisa N Colleran is at least $1.76 Million dollars as of 22 May 2020. Ms. Colleran owns over 1,165 units of Establishment Labs Inc stock worth over $1,759,742 and over the last 7 years she sold ESTA stock worth over $0. In addition, she makes $0 as Independent Director at Establishment Labs Inc.
Sign up
Ms. Colleran ESTA stock SEC Form 4 insiders trading
Lisa has made over 2 trades of the Establishment Labs Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 1,165 units of ESTA stock worth $20,772 on 22 May 2020.
The largest trade she's ever made was buying 2,835 units of Establishment Labs Inc stock on 23 May 2019 worth over $60,386. On average, Lisa trades about 267 units every 24 days since 2018. As of 22 May 2020 she still owns at least 42,931 units of Establishment Labs Inc stock.
You can see the complete history of Ms. Colleran stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lisa Colleran biography
Lisa N. Colleran serves as Independent Director of the Company. She served as Global President of LifeCell Corporation from August 2008 to January 2012 after the company was acquired by Kinetic Concepts, Inc. In January 2012, Ms. Colleran was appointed Chief Executive Officer and Director of LifeCell Corporation, a position she held until April 2013. Ms. Colleran originally joined LifeCell in 2002 as the Vice President of Marketing and Business Development and later served as Senior Vice President of Commercial Operations. Prior to joining LifeCell, Ms. Colleran spent 20 years at Baxter Healthcare Corporation in various sales, marketing, business development and general management roles with international experience. She was appointed Vice President, Marketing for Baxter's U.S. Renal business in 1997 and served in that role until 2001 when she was promoted to Vice President/General Manager of the company's Renal Pharmaceuticals business. Ms. Colleran has served on the Board of Directors of Rockwell Medical, Inc. since March 2018 and has previously served on the Board of NOVADAQ Technologies Inc. from January 2017 to August 2017 and AxoGen Corporation from July 2018 to October 2018. Ms. Colleran received her Bachelor of Science from Molloy College and an M.B.A. from Loyola University of Chicago.
How old is Lisa Colleran?
Lisa Colleran is 62, she's been the Independent Director of Establishment Labs Inc since 2015. There are 2 older and 14 younger executives at Establishment Labs Inc. The oldest executive at Establishment Labs Holdings Inc is Dennis Condon, 83, who is the Independent Director.
What's Lisa Colleran's mailing address?
Lisa's mailing address filed with the SEC is C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355.
Insiders trading at Establishment Labs Inc
Over the last 6 years, insiders at Establishment Labs Inc have traded over $8,492,826 worth of Establishment Labs Inc stock and bought 169,894 units worth $9,905,657 . The most active insiders traders include David Hung, Nicholas Sheridan Lewin und Quiros Juan Jose Chacon. On average, Establishment Labs Inc executives and independent directors trade stock every 34 days with the average trade being worth of $513,072. The most recent stock trade was executed by Quiros Juan Jose Chacon on 11 July 2024, trading 3,641 units of ESTA stock currently worth $163,991.
What does Establishment Labs Inc do?
establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.
What does Establishment Labs Inc's logo look like?
Complete history of Ms. Colleran stock trades at Axogen, Rockwell Medical Inc, Establishment Labs Inc und TELA Bio
Establishment Labs Inc executives and stock owners
Establishment Labs Inc executives and other stock owners filed with the SEC include:
-
Juan Jose Chacon Quiros,
Founder, CEO & Exec. Director -
Juan Jose Chacon Quiros,
Chief Executive Officer, Director -
Salvador Santos Dada,
Chief Operating Officer (Medical Leave of Absence) -
Renee Gaeta,
Chief Financial Officer -
Salvador Santos,
Chief Operating Officer -
Eddie De Oliveira,
Vice President of Sales Latin America -
David Erickson,
IR Contact Officer -
Edward Schutter,
Independent Director -
David Hung,
Independent Director -
Lisa Gersh,
Independent Director -
Dennis Condon,
Independent Director -
Lisa Colleran,
Independent Director -
Jeremy Livianu,
General Counsel -
Alberto Quesada,
Vice President - Quality & OUS Regulatory Affairs -
Roberto De Mezerville,
Chief Technology Officer -
Nicholas Lewin,
Chairman of the Board -
Roberto de Mezerville,
Chief Technology Officer -
Rosalyn Cole d'Incelli,
VP of Clinical & Medical Affairs -
Eddie De Oliveira,
VP of Sales, Brazil -
Dr. Heather Brennan,
Head of U.S. Commercial Operations -
Jeffrey Clark Bettinger,
Global Head of People -
Neeta Toprani,
Gen. Counsel & Corp. Sec. -
Roberto De Mezerville,
Chief Technology Officer -
Pratip Dastidar,
Head of Global Operations -
Rajbir Singh Denhoy,
CFO and Head of Strategy & Investor Relations -
Paul D. Rodio,
Chief Operating Officer -
Tu, Lp Cph,
10% owner -
Asset Management, Llcjw Par...,
-
Pratip Dastidar,
Head of Global Operations -
Ann Custin,
Director -
Bryan Slotkin,
Director -
Leslie Gillin,
Director -
Raj Denhoy,
Chief Financial Officer -
Samuel Ross Mansbach,
-
Filippo Caldini,
President